Revolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments

Chapter 1: Pathophysiology of Obesity and Diagnosis

3 chapters
0.50 credits
30 minutes
Play All
CME/CE
ReachMD Healthcare Image
Media formats available:
Details
Program chapters
Presenters
Comments
  • Overview

    Embark on a transformative journey to redefine patient care for individuals with type 2 diabetes by transitioning from the conventional focus on glycemic control to a pioneering obesity-centered approach. Immerse yourself in the expertise of 3 distinguished professionals: Drs. Carol Wysham, Scott Kahan, and Ken Fujioka. These esteemed experts will guide you through the dynamic terrain of weight loss medications, including GLP-1/GIP dual receptor agonists, and provide invaluable insights to elevate and optimize patient outcomes in the realm of type 2 diabetes management.  

  • Disclosure of Relevant Financial Relationships

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.  

    Faculty: 
    Ken Fujioka, MD 
    Director, Nutrition and Metabolic Research Center
    Scripps Clinic Del Mar
    San Diego, CA 

    Dr. Fujioka has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
    Consulting Fees: Amgen, Boehringer Ingelheim, Gelesis, Janssen Global Services, Nalpropion Pharmaceuticals, Novo Nordisk, Rhythm Pharmaceuticals 

    Scott Kahan, MD, MPH 
    Director, National Center for Weight and Wellness
    Johns Hopkins Bloomberg School of Public Health
    George Washington University School of Medicine
    Washington, DC 

    Dr. Kahan has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
    Consulting Fees: Gelesis, Lilly, Pfizer, Vivus 

    Carol Wysham, MD 
    Section Head, Department of Diabetes and Endocrinology
    Rockwood Clinic
    Spokane, WA 

    Dr. Wysham has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
    Research: Bayer, Eli Lilly, Novo Nordisk
    Consulting Fees: Abbott, Biomea, Novo Nordisk, Sanofi 

    Reviewers/Content Planners/Authors: 

    • Stephen Chavez has nothing to disclose. 
    • Cindy Davidson has nothing to disclose.  
    • Hany Ibrahim has nothing to disclose. 
    • Tim Person has nothing to disclose.  
    • Colleen Resnick has nothing to disclose. 
    • Mara Siegel has nothing to disclose. 
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:  

    • Discuss the complex, chronic, and relapsing nature of obesity and adiposity in type 2 diabetes (T2D)   
    • Identify weight loss as a primary target of treatment in people with T2D and obesity  
    • Select evidence-based treatment options that can help people with T2D and obesity achieve sustained weight loss and glycemic control 
  • Target Audience

    This activity is designed to meet the educational needs of endocrinologists and primary care physicians. 

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this enduring activity for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for .50 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Prova Education designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties. 

    Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the best education in the most impactful manner and to verify its results with progressive outcomes research. 

  • Commercial Support

    This activity is supported by an independent educational grant from Lilly USA, LLC.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to access a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site. 

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner. 

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

  • Publication Dates

    Release Date:

    Expiration Date:

Register

We're glad to see you're enjoying Prova Education…
but how about a more personalized experience?

Register for free